TickerFactsScreenerDevelopers

CHINA PHARMA HOLDINGS, INC. (CPHI) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2010: $44.11M2011: $52.18M2012: $38.66M2013: $23.41M2014: $17.22M2015: $15.78M2016: $12.35M2017: $10.74M2018: $10.36M2019: $9.44M2020: $8.91M2021: $9.29M2022: $8.60M2023: $7.29M2024: $6.51M2025: $4.28M$4.28M
2010Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$4.28M-34.4%
2024$6.51M-10.7%
2023$7.29M-15.2%
2022$8.60M-7.5%
2021$9.29M+4.3%
2020$8.91M-5.6%
2019$9.44M-8.8%
2018$10.36M-3.6%
2017$10.74M-13.0%
2016$12.35M-21.7%
2015$15.78M-8.3%
2014$17.22M-26.4%
2013$23.41M-39.5%
2012$38.66M-25.9%
2011$52.18M+18.3%
2010$44.11M—